Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2022.2071422
Abstract: ABSTRACT Introduction Esketamine was approved for adults with treatment-resistant depression (TRD) in conjunction with an oral antidepressant, and for treating depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. However,…
read more here.
Keywords:
esketamine side;
potential esketamine;
symptomatology;
craving addictive ... See more keywords